Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

This is where Hong Kong's unique identity shines. As both part of China and a globally connected offshore market, it occupies ...

China's biotechnology sector is experiencing notable growth, with the ChinaAMC Hang Seng Biotech ETF, tracking the Hang Seng ...

Shares to fall as Middle East tensions escalate; oil spikes above $US78.32; gold climbs. ASIC investigate ASX; Adnoc agrees ...

IN late May, workers of Zhejiang Yueli Electrical Co, a home appliances manufacturer based in Ningbo, Zhejiang province, were ...

The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...

Discover how U.S. biotechs can learn from China's success in affordable, high-quality drug development. Read more here.